Chemours (NYSE: CC) CEO gets 2,261 shares; 742 withheld for tax

Rhea-AI Filing Summary

Chemours Co Chief Executive Officer Denise Dignam received 2,261 shares of common stock as a performance-based stock award tied to 2023 compensation, issued at no cash cost to her after performance conditions were certified. To cover taxes on vesting, 742 shares were automatically withheld at $18.4100 per share, and the footnotes state that no shares were sold. Following these transactions and an adjustment for a prior administrative error, her directly owned and related holdings total 187,995.8721 shares, including restricted stock units and dividend equivalent units.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Dignam Denise

Role Chief Execitive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,261	$0.00	--
Tax Withholding	Common Stock	742	$18.41	$14K

Holdings After Transaction: Common Stock — 188,737.872 shares (Direct)

Footnotes (1)

1. These shares were granted to the Reporting Person as performance stock units under the Company's Long Term Incentive Plan as part of 2023 compensation and vested subject to the satisfaction of certain performance conditions, which the Company's Compensation and Leadership Development Committee certified as having occurred. The total holdings have been adjusted to correct an administrative error in prior Form 4s. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Includes directly owned shares, restricted stock units and dividend equivalent units.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dignam Denise

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Execitive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		A		2,261(1)	A	$0	188,737.8721(2)	D
Common Stock	02/24/2026		F		742(3)	D	$18.41	187,995.8721(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were granted to the Reporting Person as performance stock units under the Company's Long Term Incentive Plan as part of 2023 compensation and vested subject to the satisfaction of certain performance conditions, which the Company's Compensation and Leadership Development Committee certified as having occurred.

2. The total holdings have been adjusted to correct an administrative error in prior Form 4s.

3. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

4. Includes directly owned shares, restricted stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Chemours (CC) CEO Denise Dignam report in this Form 4?

Denise Dignam reported a stock award and related tax withholding. She received 2,261 Chemours common shares from performance stock units, and 742 shares were automatically withheld to satisfy tax obligations upon vesting, with her total reported holdings now 187,995.8721 shares including units.

How many Chemours (CC) shares were granted to the CEO in this filing?

The CEO received 2,261 shares of Chemours common stock. These shares arose from performance stock units granted under the Long Term Incentive Plan as part of 2023 compensation, after the Compensation and Leadership Development Committee certified that specified performance conditions had been met.

Were any Chemours (CC) shares sold by the CEO in this Form 4?

No shares were sold by the CEO. The filing explains that 742 shares were automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units, and explicitly notes that no shares were sold in connection with these tax-withholding transactions.

What is Denise Dignam’s total Chemours (CC) shareholding after these transactions?

After the reported transactions, her holdings total 187,995.8721 Chemours shares. The filing notes this figure includes directly owned shares, restricted stock units, and dividend equivalent units, and reflects a correction of an administrative error in previously reported Form 4 filings.

What do the performance stock units in Chemours (CC) CEO’s award represent?

The performance stock units convert into shares only if conditions are met. In this case, 2,261 units granted as part of 2023 compensation vested after performance goals were certified as achieved, resulting in delivery of an equivalent number of Chemours common shares to the CEO.

Why were some Chemours (CC) shares withheld in the CEO’s Form 4?

742 shares were automatically withheld to cover tax obligations arising from vesting awards. The filing states these shares satisfied taxes on restricted stock units and dividend equivalent units and that these transactions are exempt under Rule 16b-3, with no market sale of shares occurring.